Pharmaceutical company CJSC ARAY announced today that it is in active research and development phase of a new Hormone Replacement Therapy (HRT) drug, called SUSTADREN (TM), housed in Bishkek, Kyrgyz Republic.
The top quality active pharmaceutical ingredients and oils are going to be used as adjuvants in the product to ensure the best quality and compliance with international standards. Thus, all delivered ingredients and substances will comply with the pharmacopoeia grade requirements, including the British (BP) and European Pharmacopoeia (EP), as well as GMP.
The Company is looking to develop and produce a number of oral and injectable drugs of hormonal origin as housed by own GMP pharmaceutical plant in Bishkek, Kyrgyz Republic in the nearest future.
Let’s block ads! (Why?)
HONG KONG SAR - Media OutReach Newswire - 20 May 2024 - The Zonta Club…
The AsiaStar Award winner promotes plastic circularity and aids in waste reduction with its new…
www.HokuetsuCorpGov.com HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially…
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…